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on RNAs have revealed that these regions are often stabilized 
Abstract The ability ofasmallmolecule, 2-methyl,4-carboxy,5- by non-Watson-Crick base pairs. In HIV TAR, the three 
hydroxy-3,4,5,6-tetrahydropyrimidine (THP(A)), which aceumu- 'bulge' nucleotides are stacked between the upper and lower 
lates intracellularly in various streptomyces, to inhibit the inter- 
action of Tat peptide (R52) with TAR RNA is presented. Using stem region, which forms base-pairs (Fig. 1). Upon binding of 
gel-shift assay, we found that the inhibition constant Ki of arginine or an arginine-containingpeptide, a significant confor- 
THP(A) is 50-100 nM, which is in the range of the binding mational change in the RNA is induced. The bound TAR 
constants of Tat peptide and protein. THP(A) is ~ 106 times more RNA-arginine structure contains a new base-triple nucleotide 
tightly bound than the free L-arginine. The high binding affinity in which the essential U in the bulge (U23) forms two hydrogen 
may be attributed to the special delocalized positive charge on the bonds with an essential Watson-Crick A27-U38 base pair in 
NCN group and the hydroxyl group at the 5 position of this the major groove of the upper helix [9,10]. The nucleotides 
molecule. A model for THP(A)-TAR interaction, analogous to involved in the RNA base-triple interaction and in contacts to 
the arginine guanidinum group-TAR interaction, is presented, arginine are also those that are important for transcriptional 
The relatively high uptake of THP(A) by mammalian cells war- activation in vivo [9]. 
rants in vivo Tat/TAR inhibition studies. The guanidinum group of the arginine side chain seems well 
Key words: THP(A)/TAR-RNA binding; HIV-1-Tat/TAR suited for sequence-specific nucleic acid recognition. It is posi- 
inhibition; 2-Methyl,4-carboxy,5-hydroxy-3,4,5,6- tively charged and can form base-specific hydrogen bonds in 
tetrahydropyrimidine, THP(A); 2-Methyl,4-carboxy-3,4,5,6- the DNA major grooves [11]. In RNA recognition, arginine can 
tetrahydropyrimidine, THP(B); THP(A) uptake by mammalian form a network of hydrogen bonds with the sugar-phosphate 
cells backbone [12] and can interact with the bases [13,14]. 
Because Tat and Rev are critical for viral replication, they 
are attractive targets for therapeutic ntervention. Several pre- 
vious studies have suggested that certain classes of small mole- 
1. Introduction cules, such as amino-glycoside antibiotics may interact with 
RNA in a sequence-specific fashion [15]. 
Replication of human immunodeficiency virus (HIV) is crit- In our study of the control mechanism of actinomycin (Act 
ically dependent on two viral regulatory proteins, Tat and Rev. D) biosynthesis by Streptomycesparvulus, we found and identi- 
Tat is required in the early viral life cycle for efficient ranscrip- fled two tetrahydropyrimidine d rivatives which accumulate 
tion of the viral genome. Tat acts by binding to an RNA intracellularly: 2-methyl,4-carboxy,5-hydroxy-3,4,5,6-tetrahy- 
stem-loop structure, the trans-acting responsive element dropyrimidine (THP(A)) and 2-methyl,4-carboxy-3,4,5,6- 
(TAR), located at the 5' end of the viral mRNA (Fig. 1) [1 3]. tetrahydro-pyrimidine (THP(B)) [16-18]. The simultanesous 
A domain of basic amino acids mediate RNA recognition by onset of their synthesis with that of Act D synthesis, leads us 
Tat and peptides that correspond to this domain bind specifi- to believe that they may function in the self-defence mechanism 
cally to TAR [3-6]. of Act D-producing organisms. NMR and X-ray crystallogra- 
The RNA-binding peptide from Tat has several unusual fea- phy reveal that the THPs form zwitterionic molecules with the 
tures in addition to its small size. Even though it binds specifi- half-chair conformation (Fig. 2) [19]. The THPs are small, 
cally to TAR, the precise amino acid sequence required for highly soluble organic molecules, neutral at physiological pH, 
specific RNA binding is flexible. To ascertain whether free which do not interfere with normal cellular functions. Thus, we 
amino acids can compete with the Tat peptide (R52: Tyr-Lys- anticipate that the amidine group of the zwitterion molecules, 
Lys-Lys-Arg-Lys-Lys-Lys-Lys-Lys-Ala) for specific binding to similarly to the arginine guanidinum group, can recognize a
TAR, inhibition of R52-TAR interaction by L-arginine, L-ly- defined backbone conformation of the RNA by forming a 
sine and L-arginine derivatives was investigated by gel-shift specific network of hydrogen bonds with the sugar phosphate 
assays [7]. The inhibition constant, K~, for L-arginine was 4 mM, groups and/or interaction with the bases. 
whereas the K~ for L-lysine was >50 mM. This compares with We present evidence that a small molecule, THP(A), can 
the binding constants of Tat peptide and protein of 612 nM inhibit the interaction of Tat peptide (R52) with TAR. Using 
[7]. electrophoretic gel-shift assays, we found that the binding con- 
The conserved regions of biologically important RNAs often stant of R52-TAR was similar to the inhibition constant K~ for 
reside in loops, bulges and internal loops [8]. Structural studies THP(A) of Tat TAR binding. We predict a model for TAR- 
THP(A) or THP(B) interactions, analogous to the model pro- 
*Corresponding author. Fax: (972) (8) 344 142. posed for the TAR-arginine guanidinum group interaction de- 
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G G with at least five concentrations of Tat-peptide (R52): 60 nM of Tat was 
added to TAR to obtain 100% binding in the absence of inhibitors. 
U G Peptide-RNA complexes were resolved on 10% polyacrylamide [6]. 
Loop Gels were electrophoresed at 200 V for 3 h at 4°C, dried and visualized 
C A by autoradiography. To determine K i values, RNA-peptide bound and 
free RNA were quantitated by a fl scanner. 
C29 • G36 (a) Inhibition of Tat (R52) binding to TAR RNA by THP(A) and 
THP(B) was measured by adding several concentrations of each com- 
Upper G2~ • C,a7 pound to reaction mixtures containing peptide and RNA under condi- 
tions that gave approximately 100% binding in the absence of THP(A) 
stem [~  • O~ or THP(B). The range of concentrations of THP(A) and THP(B) is 
• C39 indicated in Figs. 3 and 4. Ki is defined as the concentration fcompe- 
titors required to decrease the fraction binding by 50%. 
(b) Binding inhibition by L-arginine was measured as previously 
U25 described [7] by adding several concentrations (inthe range 3 120 mM) 
Bulge C24 of L-arginine to reaction mixtures containing Tat peptide (R52) and 
RNA, as described above. 
f-0-g] 
A22 • U40 2.4. THP(A) and THP(B) biosynthesis 
THP(A) and THP(B) were isolated and purified as previously de- 
G21 • C scribed from S. parvulus [12,13]. THP(A) was recently obtained from 
Streptomyces griseus grown in a chemically defined medium supple- 
A • U mented with 0.5 M NaC1 (63 mg/g dry wt) as the sole tetrahydropyrim- 
idine derivative. It was isolated from other cell extract components and 
C • G purified. 
Lower C • G THP(A) and THP(B) were found to be pure by high field ]H and ]3C 
stem NMR and by reverse phase HPLC. 
G • C 
2.5. Biosynthesis of [14C]THP(A) 
GI¢ , • C46 We have previously found (Inbar and Lapidot, unpublished results) 
that [U-~3C]aspartic a id can replace [U-13C]glutamic acid as the t3C 
Fig. 1. Secondary structure of TAR RNA. Important sites for recogni- precursor for J3C labeled THP(A) and THP(B) in S. parvulus cell cul- 
tion by Tat are boxed. Data are from references cited in the text. ture. We have used this approach (with some modification) to prepare 
radioactive labeled [J4C]THP(A) from [U-14C]aspartic a id in S. griseus 
cell culture. 
rived from NMR spectroscopy by Williamson and his c01- 2.6. Uptake of [J4C/THP(A) by HeLa cells and human fibroblast cell 
leagues [9,10]. line 
HeLa cells (seeded at 15 × 106 cell/ml) were grown in Dulbecco's 
2. Materials and methods Modified Eagles Medium (DMEM) supplemented with 10% fetal calf 
serum (FCS) in a 0.5 ml dish at 37°C. After 20 h, the medium was 
2.1. Tat peptide (R52) synthesis removed, cells were washed twice with 5 ml medium (without serum) 
A Tat peptide (R52) with a single arginine at position 52, which and THP(A) was added to the cell culture at final concentrations of 0.05 
consists of nine basic amino acids and additional residues of Tyr at Lys to 1 mM. Cell growth was followed by counting, or alternatively, DNA 
NH2 and Ala at Lys COOH termini, was used in this study - Tyr-Lys- synthesis was monitored by labeling cells with [3H]dThymidine (10 
Lys-Lys-Arg-Lys-Lys-Lys-Lys-Lys-Ala. The peptide was synthesized ,uCi/ml). 
as previously described [6] by the Chemical Services Unit of the 
Weizmann Institute of Science, Tat (R52) was found to be pure by O . ~  ~ 
reverse phase high performance liquid chromatography (HPLC). c. 
2.2. TAR-RNA synthesis and purification 
TAR RNA was transcribed invitro by T7 RNA polymerase [6] from c L ~ 7 ,  ~ , ~ . ~  ~ c 
synthetic oligonucleotide templates containing a 17 base double- c c 
stranded T7 promoter and a single-stranded TAR sequence coding for 
sense TAR RNA. The TAR RNA contained sequences + 18 to +44 of 
the HIV LTR TAR site with additional GG at its 5' end, which in- 
creases the efficiency of transcription and CC at the 3' end to base pair 
with the Gs. The template containing the T7 promoter fused to the TAR 
coding sequences i as follows: 5'-CCG CAG AGA GCT CCC AGG 
CTC AGA TCT GGC CCT ATA GTG AGT CGT ATT-3' (the ol- ' 4, 
igonucleotide was prepared by the Chemical Services Unit of the H CO0- H COO" 
H H Weizmann Institute of Science). The RNA was purified on 10% poly- 
acrylamide/SM urea gels, eluted from gels in 0.5 M ammonium acetate, ~N OH "~N H 
10 mM magnesium acetate, 1 mM EDTA and 0.1% SDS, extracted , J~'\+ s~ '1}~ + ~[.~ 
twice with phenol, and precipitated with ethanol. Purified RNA was 2 H z' H 
resuspended in sterile deionized water. The concentration f the radio- H3C / ~"~ ~\  H3CJ~"~-~ .-"~,, 
labeled RNA was determined from the specific activity of the [nP]CTP HI H I H 
incorporated into the transcripts. H 
2.3. Gel-shift assay of RNA binding T[-IP(A) TI-IP(R) 
Peptide and RNA were incubated together for 10 rain in a 10/.tl 
binding reactions containing 10 mM Tris-HC1 (pH 7.5), 70 mM NaC1, Fig. 2. Molecular structure of 2-methyl,4-carboxy,5-hydroxy-3,4,5,6- 
0.2 mM EDTA and 5% glycerol, as previously described [7]. To deter- tetrahydropyrimidine (THP(A)) and 2-methyl,4-carboxy-3,4,5,6- 
mine the binding constants, 6 nM radiolabeled TAR-RNA was titrated tetrahydropyrimidine (THP(B)). 
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For the uptake experiments, [~4C]THP(A) (5 x 105 cpm) was added 1.2- 
to the washed cell culture at a final concentration of 0.5 mM and cells ~ , -----a---THP(A) 
Z t, THP(B) were cultured in DMEM (supplemented with 2% dialyzed FCS) for " 1.0, 
different incubation periods, as depicted in Fig. 4. The medium contain- m ° . 
ing [14C]THP(A) was removed, cells were washed with phosphate buff- z O.a- 
ered saline (PBS) and concentrated by centrifugation at 1500 rpm for o 
5 min at room temperature. Cells were lysed at 37°C for 18 h by a 100 ~ 0.6- 
pl NCS-tissue solubilizer (Amerhsam) and counted in lumax containing ,,m 
scintillation liquid. 0.4. iii 
Human fibroblast (R.G. foreskin cells) were grown similarly to HeLa ~ 
cells. [t4C] THP(A) was added to the culture at two final concentrations, ..a 0.8- 
0.5 and 1 mM. The effect of uptake at these two concentrations were ua 
compared to that of Hela cells. " 0 
0 10'00 2000 30'00 4000 
2. 7. A suggested mode~for THP(A) and TAR interaction 
The model of the THP(A)-TAR complex was constructed by manu- COMPETITOR THPs (nM) 
ally docking the THP(A) molecule into the observed cavity in TAR, 
using interactive computer graphics (Biosym/InsightlI). Coordinates 
of the proposed TAR-arginine complex, based on NMR data, were 
generously given to us by Dr. James R. Williamson, The structure of a Z THP(A) was taken from the crystal structure [19] except for minute = 1.0 
changes in the torsion about he C COO- and C-OH bonds. The model °m 
was not energy minimized. ~ ~ • THP(A) 
I,- 
°it 
3. Results < 
" o. tt 
3.1. Inhibition of Tat peptide binding to TAR by THP(A) 
l -  
The ability of THP(A), and to a much lesser extent of 
THP(B), to inhibit the interaction of Tat peptide to TAR-RNA 
was investigated. To simplify the analysis, we measured inhibi- 0 5'0 1 0 0 1 5 0 2 0 0 = 5 0 3 0 0 
t/on of Tat-peptide (R52) (a peptide containing a single arginine COMPETITOR THP(nM) 
within a stack of lysines, see section 2) that binds to TAR. It 
was previously shown that this Tat peptide binds with the same Fig. 4. (a) Binding curve with THP(A) was derived from the data in Fig. 
affinity and specificity as the wild type Tat 49-57 peptide (Tyr- 3. Peptide-bound RNA and free RNA were quantitated from the gels 
presented in Fig. 3 with a ,8 scanner, and the ratios of bound to free 
Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Ala) [7]. Using the RNA, relative to absence of competitors, were calculated. The binding 
curve with THP(B) was similarly derived from inhibition of Tat/TAR 
interaction by THP(B) (data not shown), as described for THP(A) in 
Fig. 3. (b) Expanded view of Fig. 4(a) at THP(A) concentration of 
THP (A) 0-200 nM. 
nM pM 
I ii I 
0 0 0 0 0  
- o r~ ,- ~ ~ N o ,- ~ o o o gel-shiftassay, we found that binding of Tat (R52) to TAR was e- t",d t-- t~ ~ID 
strongly inhibited by THP(A) (Fig. 3). The inhibition constant 
m 
Ki for THP(A) was in the range of 50-100 nM (Fig. 4). This 
compares with 100% binding of Tat (R52) to TAR at 60 nm Tat 
4-,91. freeb°Und (R52), as measured in this study, and also with binding con- 
stants of 6-12 nM for Tat (R52) to Tat peptides, previously 
reported for 50% binding [7]. The high affinity of THP(A) to 
TAR-RNA is similar to that of the Tat peptide. Inhibition of 
Tat/TAR interaction by THP(B) was measured in the pM 
A R G I N I N E (m M ) range. However, only partial inhibition was noted in this range 
(Fig. 4). The inhibition of Tat peptide (R52) binding to TAR 
- 0 3 1 0 3 0 6 01 Z 0 - by L-arginine was also measured in this study in comparison 
with THP(A) and THP(B). Inhibition by L-arginine in the mM 
bound range (Fig. 3) confirmed previous determinations [7]. The 
"4 f ree  higher affinity of THP(A) compared to THP(B) may be due to 
the hydroxyl group at position 5, which can act either as a 
proton donor or acceptor and form hydrogen bonds with RNA 
Fig. 3. Electrophoretic mobility-shift of Tat peptide (R52) binding to bases. Moreover, the high affinity of THP(A) presented in this 
TAR RNA; effect of competitors. Specific inhibition of Tat peptide/ study, in comparison to that of free L-arginine and L-arginine 
TAR interaction by THP(A) or L-arginine are presented. Tat (R52) analogues: argininamide and agmatine, which have a blocked 
peptide (60 nM) was incubated with RNA (6 nM) in the presence of 
the indicated concentration fTHP(A) (upper gel), or L-arginine (lower or deleted carboxyl group [7] suggest hat the carboxyl groups 
gel). Similar inhibition of Tat peptide/TAR interaction by THP(A) was of THP(A) or THP(B) may take part in the interaction with 
obtained for at least three other experiments. TAR-RNA.  
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3.2. THP(A) is not toxic to mammalian cells - Uptake studies 2 + . . . .  ~ . . . .  ~ . . . .  ~ . . . .  J 
of THP(A) by mammalian cells I ~ l 
Two potential problems have concerned investigators who 
develop anticancer and antiviral drugs. The first is the ability ~ 1.5--- ~ "t- u 
of a charged molecule to diffuse across the uncharged mem- ~ ! / ~ _ _ _ _ _ _ _ _ ~ ~  .1 
branes of the cells. The second, is the likelihood that com- ~ ~- ~. . /~  -----------D 
pounds like oligonucleotides that managed to enter cells would ~ 1 "S 7 
be Since e zymatically THPs degraded, neutral ~ "a < t are at physiological pH, we anticipated ~ I 
that they could diffuse across the membrane, or even that their ~" 0.5 
uptake by mammalian cells would be similar to that by E. coli, 
where high active transport occurs as a response to salt stress 
(Malin and Lapidot, unpublished results). We used radioactive 0 ~ . . . .  ~ , , , , ~ . . . .  ~ . . . .  , 
0 5 10 15 20 
labeled [14C]THP(A) for uptake studies by mammalian cells, TIME(HOURS) 
e.g., HeLa, HL 60 and a human fibroblast cell line. We exam- 
ined the cytocidal effect of THP(A) on various mammalian Fig. 5. Time dependence of [~4C]THP(A) uptake by HeLa and human 
fibroblast cell lines. HeLa cells were incubated with 0.5 mM 
ceils, including HeLa cells and a human fibroblast cell line. [~4C]THP(A) and human fibroblast cell lines were incubated with 0.5 
Neither THP(A) nor THP(B) exerted a toxic effect on these and 1 mM [14C]THP(A) for several time periods, as indicated. 
mammalian cells in a culture medium at concentrations of up 
to 1 mM of each of the THPs. 
For determination f uptake, samples of[14C]THP(A) (2,500 were manually docked into this cavity. The NH hydrogens of 
cprn/pg) at a concentration of 0.5 mM were added for different the NH-C(CH3)-NH group in THP(A) (or THP(B)) are dis- 
incubation periods as depicted in Fig. 5. The uptake of THP(A) posed similarly to the hydrogens of the NH2-C(NH2)-NH 
initially proceeded rapidly and was linear for about 6 hours group of arginine (Fig. 6b). This structural similarity makes it 
before leveling off to a steady state. The intracellular level of possible to place the THP(A) (or THP(B)) amidine group inside 
THP(A) in HeLa cells at a steady state was 1.0/~mol/106 cells, the guanidinum binding cavity of TAR. THP(A) (or THP(B)) 
Similar results were obtained for human fibroblast cells. How- mimic only two of the four hydrogen bonds formed by the 
ever, when the extracellular concentration of [tnC]THP(A) was arginine guanidinum group, involving the phosphate of A22 
1 mM, its intracellular concentration was doubled after 6 to 18 and the 06 atom of G26. However, the THP(A) (or THP(B)) 
hours of incubation with the labeled THP(A) (Fig. 5). During carboxylate group and, in particular, the hydroxyl group of 
these long periods, cells were not degraded. These findings THP(A) can also take part in the interaction with TAR (Fig. 
present a reasonably high uptake capacity of THP(A) by mam- 6c). Most hydrogen bonds proposed for THP(A)-TAR interac- 
malian cells. Thus, in vivo inhibition studies of Tat/TAR inter- tion are in the range of 2.0-2.2 A, as are those of the arginin~ 
action by THP(A) may be predicted. TAR complex. Our values are just an indication for possible 
hydrogen bonds, as the model was not energy miminized. 
3.3. A modelJor TAR-THP(A) interaction 
A model for arginine guanidinum group interaction with 4. Discussion 
TAR RNA was recently presented by Puglisi et al. [9]. The 
model, which is most consistent with NMR data, consists of a 4.1. The similarity of the arginine guanidinum group to the 
pair of hydrogen bonds between the guanidinum group and amidine group of the tetrahydropyrimidine derivatives, 
G26 in the major groove and hydrogen bonds to phosphates THP(A) and THP(B) 
P22 and P23 that are favorably positioned in the bound struc- The similarity of the arginine guanidinum group to the amid- 
ture. ine group of THP(A) or THP(B) (Fig. 2) prompted us to inves- 
The structural characteristics illustrated by the TAR bulge tigate the ability of THPs to interfere with the Tat/TAR inter- 
motif for TAR-arginine interaction [9,10] were used in this action. Our previous tudies indicated that both THP(A) and 
study to predict an analogous interaction between TAR THP(B) are zwitterionic molcules with a delocalized ~r charge 
THP(A) and TAR-THP(B). in the NCN group and form the half chair conformation [19] 
Upon binding of L-arginine to TAR-RNA, the conforma- (Fig. 2) and both NMR and X-ray crystalography techniques 
tional changes of RNA form a small cavity, which accommo- indicated that the carboxyl group of THP(B) is in the axial 
dates the guanidinum group of arginine [9]. The water-accessi- position and that the carboxyl and hydroxyl groups of THP(A) 
ble surface of TAR shown in Fig. 6a reveals the binding cavity are also in the axial position. The amidine group is positively 
for the guanidinum group. THP(A) and THP(B) molecules charged, providing a favorable lectrostatic environment for 
-4 
Fig. 6. A model of interaction of THP(A) with the bulge region of TAR is presented. THP(A) is green, its amidine group nitrogens are blue, hydroxy 
and carboxylate oxygens are red, and RNA residues are yellow or brown. Hydrogen bond distances are given in A. (a) The water accessible surface 
of TAR (yellow) reveals the binding cavity. The van der Waals surface (green) of THP(A) matches the size and shape of the cavity. (b) Comparison 
of the guanidinum group of arginine with the amidine group of THP molecules. The atoms of the similar moieties that interact in the binding cavity 
are shown as balls. (c) Interaction of THP(A) with TAR. The bond between the amidine group to G26 and P22, and the OH group to N7 and NI-I2 
group of A22, are shown, as well as the carboxylate group to A27. (d) Interaction of THP(A) with the triple mutant RNA (IV). C23-G27.C38. The 
hydrogen bonding between the amidine group and the hydroxyl group are as in the wild type (c), whereas the carboxylate group can participate in 
hydrogen bonding with the amino groups of C38 and C28 of the triple mutant (the model in (d) is presented at a different angle than that in (a)-(c)). 
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interaction with nucleic acids similarly to the guanidinum phic base triple C23-G27.C38 in the triple mutant (IV) [10] can 
group of arginine. Thus, we surmise that the amidine group can form hydrogen bonds to the THP carboxylate group via the 
donate hydrogen bonds to appropriately positioned acceptor C23 and C38 amino group protons (Fig. 6d). Thus, THP(A) can 
groups, and the hydroxyl group of THP(A) and carboxylate make a total of five or six hydrogen bonds with the wild-type 
group of THP(A) or THP(B) may also participate in the inter- TAR or its triple mutant (IV), respectively. 
action with nucleic acids. Some evidence of the functional inter- In conclusion, the structural characteristics illustrated by the 
action of THP(A) with DNA stems from our recent finding that bulge motif presented by Pugilisi et al. [9,10], is applicable in 
THP(A) protects a plasmid DNA from attack by restriction this study for THP(A) (or THP(B)) and TAR interaction. How- 
endonucleases (EcoRI, AvaL and Drut). THP(A) interacts with ever, definitive specification of the binding of THPs to TAR 
DNA and at 10 -4 M effectively protects the cleavage sites rec- must await NMR analysis. 
ognized by the restriction endonucleases (unpublished results). The high affinity of THP(A) to TAR-RNA and the fact that 
The crystal structure of EcoRI-DNA interaction [20] revealed THPs are not toxic to human cells or animals (data not shown) 
that the bundle of four parallel helices of EeoRI is electrostati- and their resistance to enzymatic degradation makes THP(A) 
cally attached to the phosphate group of the DNA backbone, a good candidate for further studies towards anew pharmaceu- 
Our results uggest that THP(A) binding to DNA prevents this tical. Preliminary studies have shown that THP(A) interferes 
interaction, with HIV replication in cultured cells (A. Lapidot, A. 
Litovchick, A. Gazit and A. Yariv, manuscript in preparation). 
4.2. A proposed mode for binding THP(A) to TAR. 
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